Evidence map›Paper›PMID 27544824›Full record

ArticleNeuropharmacology2016

An interplay between the serotonin transporter (SERT) and 5-HT receptors controls stimulus-secretion coupling in sympathoadrenal chromaffin cells.

Rebecca L Brindley, Mary Beth Bauer, Randy D Blakely, Kevin P M Currie

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rebecca L BrindleyDepartment of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Mary Beth BauerDepartment of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Randy D BlakelyDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Kevin P M CurrieDepartment of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: kevin.currie@vanderbilt.edu.
Vanderbilt University · US

Funding

Stress-Mediated Alterations in Serotonin 2C Receptor Editing and FunctionP50MH096972 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2012 to 2016
$10.5M
Serotonin transporter-mediated regulation of neuroendocrine exocytosisR21NS081492 · NINDS · VANDERBILT UNIVERSITY · PI CURRIE, KEVIN P · 2013 to 2014
$418k
NIMH NIH HHS P50 MH096972NINDS NIH HHS R21 NS081492
6 · The paper itself

Abstract

Adrenal chromaffin cells (ACCs), the neuroendocrine arm of the sympathetic nervous system, secrete catecholamines to mediate the physiological response to stress. Although ACCs do not synthesize 5-HT, they express the serotonin transporter (SERT). Genetic variations in SERT are linked to several CNS disorders but the role(s) of SERT/5-HT in ACCs has remained unclear. Adrenal glands from wild-type mice contained 5-HT at ≈ 750 fold lower abundance than adrenaline, and in SERT(-/-) mice this was reduced by ≈80% with no change in catecholamines. Carbon fibre amperometry showed that SERT modulated the ability of 5-HT1A receptors to inhibit exocytosis. 5-HT reduced the number of amperometric spikes (vesicular fusion events) evoked by KCl in SERT(-/-) cells and wild-type cells treated with escitalopram, a SERT antagonist. The 5-HT1A receptor antagonist WAY100635 blocked the inhibition by 5-HT which was mimicked by the 5-HT1A agonist 8-OH-DPAT but not the 5-HT1B agonist CP93129. There was no effect on voltage-gated Ca(2+) channels, K(+) channels, or intracellular [Ca(2+)] handling, showing the 5-HT receptors recruit an atypical inhibitory mechanism. Spike charge and kinetics were not altered by 5-HT receptors but were reduced in SERT(-/-) cells compared to wild-type cells. Our data reveal a novel role for SERT and suggest that adrenal chromaffin cells might be a previously unrecognized hub for serotonergic control of the sympathetic stress response.

Indexed as

Adrenal GlandsAnimalsCalciumCalcium Channels, N-TypeCations, DivalentCells, CulturedChromaffin CellsExocytosisMaleMembrane PotentialsMice, Inbred C57BLMice, KnockoutPotassium Channels, Voltage-GatedReceptors, SerotoninSerotoninSerotonin AgentsCalciumCalcium Channels, N-TypeCations, DivalentPotassium Channels, Voltage-GatedReceptors, SerotoninSerotoninSerotonin AgentsSerotonin Plasma Membrane Transport ProteinsSlc6a4 protein, mouse5-HT receptor8-OH-DPAT (PubChem CID: 6917794)Adrenal chromaffin cellAmperometryCalcium channelCalcium imagingCatecholamineCP93129 (PubChem CID: 124007)Escitalopram (PubChem CID: 146571)ExocytosisGallein (PubChem CID: 73685)GPCRSerotonin hydrochloride (PubChem CID: 160436)Serotonin transporterWAY100635 (PubChem CID: 11957721)

Identifiers

PMID27544824
PMCPMC5028315
OpenAlexW2513237461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.